Trials / Unknown
UnknownNCT05259020
To Evaluate the Pharmacokinetics and the Safety of ID14009 Compared to Coadministration of ID1805 With ID1803 in Healthy Adult Volunteers
An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Cross-over, Clinical Trial to Evaluate the Pharmacokinetics and the Safety of ID14009 Compared to Coadministration of ID1805 With ID1803 in Healthy Adult Volunteers.
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- IlDong Pharmaceutical Co Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the pharmacokinetics and the safety of ID14009 compared to coadministration of ID1805 with ID1803 in healthy adult volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | ID140009 | Combination Product: ID140009 Ezetibmibe 10mg/ Rosuvastatin Ca 20.8mg/ Amlodipine 10mg/ Valsartan 160mg |
| COMBINATION_PRODUCT | ID1803+ID1805 | (Amlodipine 10mg/Valsartan 160mg)+(Ezetibmibe 10mg/ Rosuvastatin Ca 20.8mg) |
Timeline
- Start date
- 2022-02-22
- Primary completion
- 2022-03-30
- Completion
- 2022-03-30
- First posted
- 2022-02-28
- Last updated
- 2022-02-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05259020. Inclusion in this directory is not an endorsement.